483 related articles for article (PubMed ID: 17619861)
21. Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.
Fuentealba JA; Gysling K; Magendzo K; Andrés ME
J Neurosci Res; 2006 Aug; 84(2):450-9. PubMed ID: 16676328
[TBL] [Abstract][Full Text] [Related]
22. Differential modulation of a 40 kDa catecholamine regulated protein in the core and shell subcompartments of the nucleus accumbens following chronic quinpirole and haloperidol administration in the rat.
Gabriele J; Thomas N; N-Marandi S; Mishra R
Synapse; 2007 Oct; 61(10):835-42. PubMed ID: 17603808
[TBL] [Abstract][Full Text] [Related]
23. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593.
Shippenberg TS; LeFevour A; Thompson AC
Eur J Pharmacol; 1998 Mar; 345(1):27-34. PubMed ID: 9593590
[TBL] [Abstract][Full Text] [Related]
24. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
25. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
Le Foll B; Diaz J; Sokoloff P
Synapse; 2003 Mar; 47(3):176-83. PubMed ID: 12494400
[TBL] [Abstract][Full Text] [Related]
26. Divergent effects of D₂/₃ receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive rats.
Moreno M; Economidou D; Mar AC; López-Granero C; Caprioli D; Theobald DE; Fernando A; Newman AH; Robbins TW; Dalley JW
Psychopharmacology (Berl); 2013 Jul; 228(1):19-30. PubMed ID: 23407782
[TBL] [Abstract][Full Text] [Related]
27. Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats.
Fraioli S; Cioli I; Nencini P
Behav Brain Res; 1997 Dec; 89(1-2):199-215. PubMed ID: 9475627
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
Cook CD; Newman JL; Winfree JC; Beardsley PM
Pharmacol Biochem Behav; 2004 Feb; 77(2):309-18. PubMed ID: 14751459
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine.
Vanderschuren LJ; Schoffelmeer AN; Mulder AH; De Vries TJ
Psychopharmacology (Berl); 1999 Apr; 143(3):244-53. PubMed ID: 10353426
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593.
El Daly E; Chefer V; Sandill S; Shippenberg TS
J Neurochem; 2000 Apr; 74(4):1553-62. PubMed ID: 10737612
[TBL] [Abstract][Full Text] [Related]
31. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
Sammut S; Bray KE; West AR
Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
[TBL] [Abstract][Full Text] [Related]
32. Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
Fuentealba JA; Gysling K; Andrés ME
Synapse; 2007 Sep; 61(9):771-7. PubMed ID: 17568430
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
Bordet R; Ridray S; Schwartz JC; Sokoloff P
Eur J Neurosci; 2000 Jun; 12(6):2117-23. PubMed ID: 10886351
[TBL] [Abstract][Full Text] [Related]
34. Multigenerational effects of adolescent morphine exposure on dopamine D2 receptor function.
Byrnes JJ; Johnson NL; Carini LM; Byrnes EM
Psychopharmacology (Berl); 2013 May; 227(2):263-72. PubMed ID: 23314440
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments.
Dvorkin A; Culver KE; Szechtman H
Psychopharmacology (Berl); 2006 Jul; 186(4):534-43. PubMed ID: 16758240
[TBL] [Abstract][Full Text] [Related]
36. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
Hoque KE; West AR
Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
[TBL] [Abstract][Full Text] [Related]
37. Regulation of dynorphin gene expression by kappa-opioid agonist treatment.
Collins S; D'Addario C; Romualdi P; Candeletti S; Izenwasser S
Neuroreport; 2002 Jan; 13(1):107-9. PubMed ID: 11924869
[TBL] [Abstract][Full Text] [Related]
38. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow.
Koeltzow TE; Austin JD; Vezina P
Neuropharmacology; 2003 Jan; 44(1):102-10. PubMed ID: 12559127
[TBL] [Abstract][Full Text] [Related]
39. Plasticity-Related Activity in the Hippocampus, Anterior Cingulate, Orbitofrontal, and Prefrontal Cortex Following a Repeated Treatment with D
Brozka H; Alexova D; Radostova D; Janikova M; Krajcovic B; Kubík Š; Svoboda J; Stuchlik A
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440912
[TBL] [Abstract][Full Text] [Related]
40. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex.
Zenko M; Zhu Y; Dremencov E; Ren W; Xu L; Zhang X
J Neurosci Res; 2011 Aug; 89(8):1245-58. PubMed ID: 21557291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
